Arcadia Biosciences, Inc. (RKDA) |
| 1.115 -0.065 (-5.51%) 04-20 16:00 |
| Open: | 1.19 |
| High: | 1.26 |
| Low: | 1.11 |
| Volume: | 27,419 |
| Market Cap: | 2(M) |
| PE Ratio: | -0.65 |
| Exchange: | NASDAQ Capital Market |
| Industry: | Agricultural Inputs |
| Sector: | Basic Materials |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 1.92 |
| Resistance 1: | 1.60 |
| Pivot price: | 1.31 |
| Support 1: | 1.10 |
| Support 2: | 0.91 |
| 52w High: | 6.71 |
| 52w Low: | 0.89 |
Arcadia Biosciences, Inc. produces and markets plant-based health and wellness products in the United States. It engages in developing crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health and wellness products, and their viability for industrial applications. The company was incorporated in 2002 and is headquartered in Davis, California.
Financials
| EPS | -1.710 |
| Book Value | 3.020 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.850 |
| Profit Margin (%) | -48.15 |
| Operating Margin (%) | -152.61 |
| Return on Assets (ttm) | -32.7 |
| Return on Equity (ttm) | -45.1 |
Company news
Fri, 03 Apr 2026
Auditor change at Arcadia Biosciences (NASDAQ: RKDA) with control weaknesses disclosed - Stock Titan
Thu, 26 Mar 2026
Arcadia Biosciences: Q4 Earnings Snapshot - 10TV
Thu, 26 Mar 2026
Arcadia Biosciences: Q4 Earnings Snapshot - KTEN
Thu, 26 Mar 2026
Arcadia Biosciences (RKDA) Announces Fourth-Quarter and Full-Year 2025 Financial Results and Business Highlights - GlobeNewswire
Thu, 26 Mar 2026
Arcadia drops Roosevelt deal, turns to Zola growth and $2.1M cash - Stock Titan
Mon, 12 Jan 2026
Arcadia Biosciences (RKDA) Announces Exercise of Preferred Investment Options for $2.1 Million Gross Proceeds - Yahoo Finance
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
